OpGen Inc (OPGN) - מכירות החברה

The scaling potential of OpGen, Inc. (OPGN) through the sale of hospital consumables is facing a profound management crisis and a loss of investor confidence. Corporate sales on this chart visualize this gap, where the current status equals 0.00. Technological stagnation exacerbates the situation: due to a lack of funds, the development of new infection diagnostic methods has completely ceased.

OpGen, Inc. generates revenue through the sale of molecular diagnostic systems and consumables for analyzing pathogen antibiotic resistance. The dynamics of the company's commercial sales volumes reveal a hidden outflow of institutional capital: local dips in daily receipts against a backdrop of stagnating quotes signal either a critical vulnerability in the business model or the formation of an optimal entry point for a long-term investor.